You are here

  • Home
  • Archive
  • Volume 58, Issue 9
  • A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

Citation Tools

Article menu
XML
Oesophagus
A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Keywood C, Wakefield M, Tack J
A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
Gut 2009;58:1192-1199.